NLRP3 and Disorder of lipid metabolism: Given that the NLRP3 inflammasome contributes to hepatocyte lipid metabolism disorders 27, we next examined whether inhibiting NLRP3 with Cas9/gNLRP3@M-N could attenuate hepatic steatosis in GAN diet-fed mice.